Decision of 22/05/2023 defining the form, content and procedures for the reporting of adverse events and new developments in the field of research mentioned in research mentioned in 1° of Article L. 1121-1 of the French public health code concerning medicinal products for human use.

5 June 2023 All news

https://ansm.sante.fr/actualites/decision-du-22-05-2023-fixant-la-forme-le-contenu-et-les-modalites-des-declarations-deffets-indesirables-et-des-faits-nouveaux-dans-le-cadre-de-recherche-mentionnee-au-1deg-de-larticle-l-1121-1-du-csp-portant-sur-un-medicament-a-usage-humain